Enterprise Value
173.5M
Cash
60.03M
Avg Qtr Burn
-18.8M
Short % of Float
25.05%
Insider Ownership
1.62%
Institutional Own.
95.15%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|---|---|
OTX-2002 Details Cancer, Hepatocellular carcinoma, Liver cancer | Phase 1/2 Data readout |